Your browser doesn't support javascript.
loading
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
Badi, Yusef Eamon; Pavel, Ana B; Pavlidis, Stelios; Riley, John H; Bates, Stewart; Kermani, Nazanin Zounemat; Knowles, Richard; Kolmert, Johan; Wheelock, Craig E; Worsley, Sally; Uddin, Mohib; Alving, Kjell; Bakke, Per S; Behndig, Annelie; Caruso, Massimo; Chanez, Pascal; Fleming, Louise J; Fowler, Stephen J; Frey, Urs; Howarth, Peter; Horváth, Ildikó; Krug, Norbert; Maitland-van der Zee, Anke H; Montuschi, Paolo; Roberts, Graham; Sanak, Marek; Shaw, Dominick E; Singer, Florian; Sterk, Peter J; Djukanovic, Ratko; Dahlen, Sven-Eric; Guo, Yi-Ke; Chung, Kian Fan; Guttman-Yassky, Emma; Adcock, Ian M.
Afiliação
  • Badi YE; National Heart and Lung Institute, the Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom; Data Science Institute, Imperial College London, London, United Kingdom.
  • Pavel AB; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Biomedical Engineering, The University of Mississippi, Oxford, Miss.
  • Pavlidis S; Data Science Institute, Imperial College London, London, United Kingdom.
  • Riley JH; GSK Respiratory Therapeutic Area Unit, Stevenage, United Kingdom.
  • Bates S; GSK Respiratory Therapeutic Area Unit, Stevenage, United Kingdom.
  • Kermani NZ; Data Science Institute, Imperial College London, London, United Kingdom.
  • Knowles R; Knowles Consulting, Stevenage, United Kingdom.
  • Kolmert J; Centre for Allergy Research, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Wheelock CE; Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Worsley S; GSK Value Evidence and Outcomes, Brentford, United Kingdom.
  • Uddin M; Respiratory Global Medicines Development, AstraZeneca, Gothenburg, Sweden.
  • Alving K; Department of Women's and Children's Health: Paediatric Research, Uppsala University, Uppsala, Sweden.
  • Bakke PS; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Behndig A; Department of Public Health and Clinical Medicine, Division of Medicine/Respiratory Medicine, Umeå University, Umeå, Sweden.
  • Caruso M; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Chanez P; Aix-Marseille Universite, Assistance Publique des Hopitaux de Marseille, Clinic des Bronches, Allergies et Sommeil, Marseille, France.
  • Fleming LJ; National Heart and Lung Institute, the Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom.
  • Fowler SJ; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; Manchester Academic Health Science Centre and NIHR Biomedical Research Centre, Manchester University Hospitals NHS F
  • Frey U; University Children's Hospital Basel, University of Basel, Basel, Switzerland.
  • Howarth P; Clinical and Experimental Sciences and Human Development in Health, University of Southampton Faculty of Medicine, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; David Hide Asthma and Allerg
  • Horváth I; Department of Public Health, Semmelweis University, Budapest, Hungary.
  • Krug N; Fraunhofer ITEM, Hannover, Germany.
  • Maitland-van der Zee AH; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Montuschi P; Pharmacology, Catholic University of the Sacred Heart, Agostino Gemelli University Hospital Foundation, Rome, Italy.
  • Roberts G; Clinical and Experimental Sciences and Human Development in Health, University of Southampton Faculty of Medicine, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; David Hide Asthma and Allerg
  • Sanak M; Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Shaw DE; University of Nottingham, NIHR Biomedical Research Centre, Nottingham, United Kingdom.
  • Singer F; Division of Respiratory Medicine, Department of Paediatrics, Inselspital, University of Bern, Bern, Switzerland.
  • Sterk PJ; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Djukanovic R; Clinical and Experimental Sciences and Human Development in Health, University of Southampton Faculty of Medicine, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; David Hide Asthma and Allerg
  • Dahlen SE; Centre for Allergy Research, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
  • Guo YK; Data Science Institute, Imperial College London, London, United Kingdom.
  • Chung KF; National Heart and Lung Institute, the Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom.
  • Guttman-Yassky E; Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Adcock IM; National Heart and Lung Institute, the Imperial College London, London, United Kingdom; NIHR Imperial Biomedical Research Centre, London, United Kingdom. Electronic address: ian.adcock@imperial.ac.uk.
J Allergy Clin Immunol ; 149(1): 89-101, 2022 01.
Article em En | MEDLINE | ID: mdl-33891981
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucinas / Dermatite Atópica / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucinas / Dermatite Atópica / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2022 Tipo de documento: Article